PERCEPTIVE ADVISORS LLC 13D and 13G filings for Crinetics Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-03-01 8:05 pm Sale |
2023-05-24 | 13D | Crinetics Pharmaceuticals, Inc. CRNX |
PERCEPTIVE ADVISORS LLC | 1,488,703 1.900% |
-3,844,829 (-72.09%) |
Filing |
| 2022-04-25 7:02 pm Unchanged |
2022-04-25 | 13D | Crinetics Pharmaceuticals, Inc. CRNX |
PERCEPTIVE ADVISORS LLC | 5,333,532 10.000% |
0 (Unchanged) |
Filing |
| 2022-04-20 9:17 pm Purchase |
2022-04-18 | 13D | Crinetics Pharmaceuticals, Inc. CRNX |
PERCEPTIVE ADVISORS LLC | 5,333,532 10.000% |
1,674,151 (+45.75%) |
Filing |